Get access

Gynaecological malignancies in pregnancy: A review

Authors

  • Martin K. Oehler,

    Corresponding author
    1. Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia
      Dr Martin K. Oehler, Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales 2145, Australia. Email: m.k.oehler@web.de
    Search for more papers by this author
  • Gerard V. Wain,

    1. Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia
    Search for more papers by this author
  • Alison Brand

    1. Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia
    Search for more papers by this author

Dr Martin K. Oehler, Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales 2145, Australia. Email: m.k.oehler@web.de

Abstract

Gynaecological malignancies frequently occur in women of reproductive age and are estimated to complicate approximately one in 1000 pregnancies. The incidence of gynaecological malignancies during pregnancy is expected to rise as more women delay childbearing into their later reproductive years, and maternal age is the most powerful predictor of cancer risk. Pregnancy-associated malignancies present significant challenges as a result of the conflict between optimal maternal therapy and fetal well-being. The lack of prospective randomised treatment studies has prevented the development of clinical guidelines for most of the issues complicating the management. In the present review, recent diagnostic and treatment strategies for cervical, ovarian, vulvar and endometrial carcinomas during pregnancy are presented.

Get access to the full text of this article

Ancillary